CNS-102

N/A

Report date: 2024/10/28 14:42:24
NME

Base Information

Drug NameCNS-102
Drug Alias NameCNS-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCoyote Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoyote Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A